RESHAPE LIFESCIENCES INC (RSLS)

US76090R2004 - Common Stock

0.1653  -0.01 (-3.16%)

After market: 0.17 +0 (+2.84%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

RESHAPE LIFESCIENCES INC

NASDAQ:RSLS (4/19/2024, 7:14:21 PM)

After market: 0.17 +0 (+2.84%)

0.1653

-0.01 (-3.16%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap3.88M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

RSLS Daily chart

Company Profile

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. The company is headquartered in San Clemente, California and currently employs 40 full-time employees. The company went IPO on 2016-10-06. The firm offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease throughout the care continuum. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. Its ReShapeCare virtual health coaching program is a weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients. Its ReShapeMarketplace online store provides top-of-the-line products with bariatric patients in mind. Its ReShapeOptimize supplement options, purchased through the ReShape Marketplace, include multivitamins, probiotics, calcium, vitamin D, protein, and other therapeutic offerings to optimize health.

Company Info

RESHAPE LIFESCIENCES INC

1001 Calle Amanecer

San Clemente CALIFORNIA 92673

P: 19494296680

CEO: Andrew Rasdal

Employees: 40

Website: https://www.reshapelifesciences.com/obalon/

RSLS News

News Image19 days ago - ReShape Lifesciences IncReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
News Image19 days ago - ReShape Lifesciences IncReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update

Completed First Surgeries With Next-Generation Lap-Band® 2.0 FLEX 2024 Operating Expenses Expected to Decrease by more than 50% Compared to 2023;...

News Image23 days ago - ReShape Lifesciences IncReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System

Patent Significantly Strengthens Intellectual Property Portfolio

News Image23 days ago - ReShape Lifesciences IncReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System

Patent Significantly Strengthens Intellectual Property Portfolio...

News Image2 months ago - ReShape Lifesciences IncReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
News Image2 months ago - ReShape Lifesciences IncReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX

2024 Operating Expenses Expected to Decrease by 55.4% Compared to 2023 Company Reaffirms Commitment to Profitability High Priority Search for...

RSLS Twits

Here you can normally see the latest stock twits on RSLS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example